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FAM111A Mutations Result in Hypoparathyroidism
and Impaired Skeletal Development
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Kenny-Caffey syndrome (KCS) and the similar but more severe osteocraniostenosis (OCS) are genetic conditions characterized by
impaired skeletal development with small and dense bones, short stature, and primary hypoparathyroidism with hypocalcemia. We
studied five individuals with KCS and five with OCS and found that all of them had heterozygous mutations in FAM111A.Onemutation
was identified in four unrelated individuals with KCS, and another one was identified in two unrelated individuals with OCS; all
occurred de novo. Thus, OCS and KCS are allelic disorders of different severity. FAM111A codes for a 611 amino acid protein with
homology to trypsin-like peptidases. Although FAM111A has been found to bind to the large T-antigen of SV40 and restrict viral repli-
cation, its native function is unknown. Molecularmodeling of FAM111A shows that residues affected by KCS andOCSmutations do not
map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the
pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis. FAM111A appears to
be crucial to a pathway that governs parathyroid hormone production, calcium homeostasis, and skeletal development and growth.In 1966, Kenny and Linarelli described a mother and son
who had severe short stature (‘‘dwarfism’’), thin long bones
with narrow diaphysis, and bouts of hypocalcemia.1 In
1967, Caffey described the radiographic features of the
same individuals in more detail.2 The condition has since
been known as Kenny-Caffey syndrome (KCS [MIM
127000]) (Figures 1A–1D). Among its clinical features are
delayed closure of fontanels, defective dentition, small
eyes with hypermetropia, and frontal bossing with a trian-
gular face. Individuals with KCS often have recurrent
hypocalcemia with inappropriately low levels of parathy-
roid hormone (PTH), and the majority of affected individ-
uals require continuous treatment with activated vitamin
D and calcium3–5 (see also Table 1). In 1994, Verloes and
coworkers coined the name osteocraniostenosis (OCS
[MIM 602361]) for a perinatally lethal condition character-
ized by gracile bones with thin diaphyses, premature
closure of basal cranial sutures, and microphthalmia.6–8
The name refers to the narrowing (‘‘stenosis’’) of the med-
ullary cavity of the long bones and of the skull (Figures
1E–1G and 2). In both KCS and OCS, skeletal radiology
shows that bone density is increased, whereas the individ-1Department of Pediatrics, Lausanne University Hospital, University of Lau
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also share other features, such as microphthalmia and a
triangular face with frontal bossing. In addition, although
hypocalcemia was not observed in the original descrip-
tion,6 most OCS-affected individuals who survive beyond
the perinatal period develop hypocalcemia with low PTH
(Table 1). On the basis of these observations, we speculated
that OCS and KCS might be allelic disorders.
All individuals in our series were ascertained by physi-
cian-initiated referral and diagnosed with KCS or OCS by
the combination of radiographic changes, facial appear-
ance, and, for most individuals (see Table 1), hypoparathy-
roidism and hypocalcemia. The diagnosis of OCS was
given to those individuals who had apparent cranial defor-
mity at birth and dense but thin bones with obliteration of
the medullary cavity on radiographs (Figure 1); four of
them did not survive beyond the newborn period, whereas
individual 9 (Table 1) is alive at age 21 months. The
five individuals with KCS all have severe short stature, a
typical facial appearance with a prominent forehead and
small eyes, and medullary stenosis on skeletal radio-
graphs but no life-threatening complications except forsanne, 1011 Lausanne, Switzerland; 2Medical Genetics Service, Lausanne
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Figure 1. Phenotypic Features of KCS
and OCS
(A) Individual1 (c.1706G>A [p.Arg569His])
at age 8 years. Note short stature (95 cm)
and frontal bossing with a triangular face
and small eyes.
(B and C) Radiographs of individual 2
(c.1706G>A [p.Arg569His]) at age 14 years.
The arrowheads indicate the increased
thickness of the cortical bone (B) and
the narrowing of the medullary cavity of
tubular bones (C) (diaphyseal stenosis).
(D) Skull radiograph of individual 1 at age
25 years. Note V-shaped orbital roofs (sec-
ondary to basal craniosynostosis; compare
to F) and extensive dental prosthetization.
(E) Facial appearance of individual 7
(c.1026_1028delTTC [p.Ser342del]) at a
few days of age. Note frontal bossing,
bitemporal narrowing with supra-auricular
bulging, low-set ears, and small, deep-set
eyes; compare to (A).
(F) Skull radiograph of individual 6
(c.1026_1028delTTC [p.Ser342del]). There
is hypomineralization of the cranial vault,
and the configuration of the orbital region
indicates basal craniosynostosis (compare
to D).
(G) Babygram of individual 6. The skeletal
elements have a dense appearance. The
long bones are thin, and the medullary
cavity isnot recognizable (‘‘osteostenosis’’).
(H) Simplified scheme of FAM111A. The green domain has homology to trypsin-like peptidases, and the residues indicated in blue
constitute the conserved putative catalytic triad. The changes predicted by the mutations observed in individuals with KCS and OCS
are indicated in orange (KCS) and red (OCS).hypocalcemia; notably, their mental development is
strictly normal. The study was approved by the cantonal
ethic committee of Lausanne, Switzerland, and informed
consent for molecular studies was obtained from the
affected individuals or their legal guardians.
Mother-to-son transmission in the original description
of KCS and absence of affected siblings in our population
of individuals diagnosed with KCS or OCS (Table 1) led
us to hypothesize dominant inheritance with a majority
of de novo mutations. Whole-exome data obtained on
four affected individuals (three with OCS and one with
KCS), revealed a single gene, FAM111A (RefSeq accession
number NM_001142519.1), harboring heterozygous
mutations in all of them (see Tables S1 and S2, available
online). Direct mutation analysis in an additional group
of six individuals (two with OCS and four with KCS)
revealed the presence of FAM111A mutations in all (Table
1, Figure 1H, and Figure S1). The c.1706G>A (p.Arg569His)
transition was detected in four of the five unrelated
KCS-affected individuals, aged 6months to 40 years; occur-
rence of this mutation at a CpG dinucleotide might
partially explain the recurrence. The c.1026_1028delTTC
(p.Ser342del) mutation (which occurs at a short triplet
repeat) was detected in two of the five unrelated OCS-
affected individuals, both of whom died in the newborn
period.
All affected individuals in our series were simplex cases,
and all parents were clinically unaffected and of normalThe Amstature. DNA samples were available from 15 of 20 parents
(family relationships were confirmed through microsatel-
lite testing): all tested parents were wild-type for the respec-
tive FAM111A mutation in their offspring, confirming
the de novo status of mutations in seven probands,
including three with the recurrent mutation c.1706G>A
(p.Arg569His) and two with c.1026_1028delTTC
(p.Ser342del) (Table 1). No individuals meeting our diag-
nostic criteria were found to be wild-type for FAM111A,
confirming the specificity of the criteria and the genetic
homogeneity of KCS and OCS. Importantly, none of the
four individuals who were subjected to whole-exome
sequencing had mutations in tubulin-folding cofactor
E (TBCE [MIM 604934]), the gene associated with the
recessive disorder Sanjad-Sakati syndrome (MIM 241410;
hypoparathyroidism, short stature, intellectual disability,
and seizures; also known as recessive KCS), which has par-
tial clinical overlap with KCS.10 Thus, the genetic data
indicate that heterozygous mutations in FAM111A are
the genetic cause of both KCS and OCS, confirming the
hypothesis of dominance and allelism of the two disorders
and establishing a new dysplasia family. The observation
that p.Arg569His is consistently associated with a moder-
ate phenotype (closely corresponding to the original
description of KCS1,2) but that p.Ser342del is associated
with the lethal phenotype of OCS6 indicates a close geno-
type-phenotype correlation, comparable to that of FGFR3-
related disorders.11erican Journal of Human Genetics 92, 990–995, June 6, 2013 991
Table 1. Clinical Features, Origin, and Molecular Findings in Subjects with KCS or OCS
Subject Gender Origin
Clinical
Diagnosis
Age at
Follow-up
Presence of
Hypocalcemia
Length or
Staturea Other Features
FAM111A Mutationsb
Predicted FAM111A
SubstitutionProband Mother Father
1 F Switzerland KCS 40 years yes 6 SDs defective dentition,
premature shedding,
hypermetropia, cataracts,
hypoacusis, high-pitched
voice
c.1706G>A WT WT p.Arg569His
2 M India KCS 17 years yes 6 SDs defective dentition,
hypermetropia
c.1706G>A WT NA p.Arg569His
3 M Germany KCS 10 years NA 7 SDs hypermetropia c.1706G>A NA NA p.Arg569His
4 F Italy KCS 6 months yes 2 SDs at birth,
3 SDs at 6 months
- c.1706G>A WT WT p.Arg569His
5 M India KCS 7 years NA 5 SDs open anterior fontanel,
defective dentition,
high-pitched voice
c.1531T>C NA NA p.Tyr511His
6 M Sweden OCS deceased at
age 3 days
yes 5 SDs micropenis, asplenia
at autopsy
c.1026_1028delTTC WT WT p.Ser342del
7 M Italy OCS deceased at
age 25 days
yes 3 SDs at birth micropenis, spleen
present, extramedullary
haemopoiesis
c.1026_1028delTTC WT WT p.Ser342del
8 M Chile OCS deceased at
age 2 months
yes 5 SDs at birth femoral fracture at birth,
microphthalmia
c.1012A>G WT WT p.Thr338Ala
9 M Sweden OCS age 20 months yes 6 SDs at birth hydrocephalus (requiring
shunt), seizures, micropenis,
bone fragility, severe failure
to thrive, hepatopathy,
developmental delay
c.1583A>G WT WT p.Asp528Gly
10 M Japan OCS deceased at
age 8 months
yes 3.5 SDs at birth hydrocephalus, micropenis, c.1579C>A WT WT p.Pro527Thr
Abbreviations are as follows: M, male; F, female; NA, not applicable; WT, wild-type; and NA, not available.
aLength for babies and stature for children and adults.
bIn affected subjects, all FAM111A mutations were found to be heterozygous.
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Figure 2. Skeletal Pathology of an OCS-
Affected Newborn, Case 7, Who Died at
Age 25 Days
(A) Macroscopic view of the left femur.
Note the thin diaphysis with splayed
metaphyses. The cartilagineous epiphyses
appear macroscopically normal. Compare
with the radiographic appearance in
Figure 1G.
(B) Representative view of the growth-
plate architecture at the proximal femur
(magnification is approximately 2003).
The overall architecture is preserved. The
chondrocyte columns are slightly shorter
and plumper than normal, and most of
them have a polyclonal rather thanmono-
clonal appearance. The inset (magnifica-
tion is approximately 43) shows the local-
ization of the larger panel on the whole
mount.
(C) Representative view of the diaphyseal
cortex of the femur (magnification is
approximately 2003); the inset (magnification is approximately 43) shows the localization of the larger panel on the whole mount.
The cortical bone is thicker than normal (as also appreciable on the radiographs). The bone trabeculae are thicker, and the lacunae
are reduced. The osteoid lamellae have an unusual wavy appearance. These findings correlate well with the findings in parathyroid
hormone (PTH)-ablated mice.9The role of FAM111A in the cell is unknown. All major
transcripts of FAM111A encode a protein of 611 amino
acids; the carboxy-terminal half of the protein has homol-
ogy to trypsin-like peptidases, and the catalytic triad spe-
cific to such peptidases is conserved. Fine and coworkers
recently reported that the LT antigen of the SV40 virus
has a strong and specific interaction with FAM111A and
that abolition of FAM111A expression results in reestablish-
ment of the viral-host-range phenotype, indicating that
FAM111A has antiviral properties.12 They found no
evidence, however, that the LT antigen itself is cleaved
by FAM111A.12 In all cell types used in their study,
FAM111A was present in both the nucleus and the
cytoplasm, and its expression was strongly cell-cycle
dependent. As observed by Fine and coworkers,12 other
LT-interacting proteins, such as RB, p53, FBXW7, and
CDC73, are involved in gene transcription and are bona
fide tumor suppressors. Nuclear localization, cell-cycle-
dependent expression, and LT binding suggest that
FAM111A might be involved in the regulation of gene
transcription.
The mutations identified in the KCS and OCS individ-
uals result in the substitution or deletion of single amino
acids that are phylogenetically conserved (Figure S2), and
they do not include frameshifts or premature termina-
tions, suggesting that simple haploinsufficiency is not
sufficient to produce the KCS and OCS phenotypes. This
notion is supported by the observation of an early
FAM111A frameshift mutation with a relatively high fre-
quency of approximately 0.5% in the data from the
National Heart, Lung, and Blood Institute (NHLBI) Exome
Sequencing Project Exome Variation Server (EVS). None of
the KCS and OCS mutations are listed in current databases
(including the 1000 Genomes Project13 and the NHLBI
EVS14) or in data from the CoLaus study.15 The CatalogueThe Amof SomaticMutations in Cancer (COSMIC) lists a FAM111A
c.1705C>G (p.Arg569Gly) transversion seen in one sam-
ple of ovarian cancer but not present in the >12,000
exomes on the NHLBI EVS; this variation could point to
a critical function of residue Arg569.
Given the lack of data on the physiologic function of
FAM111A, we used molecular modeling to obtain insight
on the structural consequences of the KCS and OCS muta-
tions, particularly on their possible impact on the putative
proteolytic active site of FAM111A. A comparative model
of the tertiary structure of the C-terminal domain of
FAM111A was obtained and used for mapping the residues
affected by the mutations. In this model, the KCS and OCS
altered residues are found in the linker region preceding
the protease domain and in the loops connecting the
core secondary-structure elements of the protease domain;
they do not map at or near the putative active site but
rather cluster on one segment of the protein, at or close
to its outer surface (Figure S3). Although a reduction of pro-
teolytic activity through an effect on protein folding or the
conformation of the active site cannot be formally
excluded, it seems unlikely, also from the genetic consider-
ations (see above). If the enzymatic activity is unlikely to
be affected, how would the heterozygous mutations pro-
duce such remarkable phenotypes? As seen in the surface
representations (Figure S3), Thr338, Ser341–Ser343, and
Arg569 are adjacent to each other, and Tyr511, Pro527,
and Asp528 are equally close to each other in an adjacent
area; thus, all altered residues are at, or close to, the surface
of a restricted area of the protein and would be well posi-
tioned to participate in intermolecular interactions, such
as the binding between FAM111A and its physiologic part-
ner(s). A plausible model to explain the findings would be
to assume that FAM111A is active when unbound but
inactive when bound by an (as yet unidentified) partnererican Journal of Human Genetics 92, 990–995, June 6, 2013 993
protein. If the KCS and OCS mutations weaken or prevent
binding of FAM111A by its inactivating partner, the conse-
quence would be increased and/or deregulated FAM111A
activity, a gain-of-function effect that would be observed
even in heterozygosity. Thismodel would also fit the obser-
vations by Fine and coworkers: binding of FAM111A by
the LT-antigen of SV40 occurs at the C-terminal domain
of FAM111A and has similar biological consequences
to FAM111A knockdown, i.e., reduced activity of
FAM111A.12
The salient phenotypic features of KCS and OCS are skel-
etal (tiny boneswith constrictedmedullary cavities that fail
to grow properly, dysfunction of the cranial sutures, and
defective dentition) and endocrine (primary hypoparathy-
roidism with hypocalcemia). This combination of skeletal
and endocrine findings can be explained by prenatal-onset
deficiency or dysfunction of PTH. In addition to its funda-
mental role in plasma calciumhomeostasis after birth, PTH
is necessary for the differentiation and proliferation of skel-
etal elements in the fetus. Pth/ mice are smaller than
wild-type mice at birth, and their long bones are shortened
and display increased cortical bone density and a reduced
number of osteoclasts,9 recapitulating the skeletal features
of KCS and OCS. On the other hand, autosomal-recessive
hypoparathyroidism (MIM 146200), due to mutations in
either GCM2 (MIM 603716), a differentiation factor for
parathyroid glands,16,17 or PTH (MIM 168450) itself,18 is
not associated with skeletal dysplasia and related features
of KCS and OCS, indicating that FAM111A mutations
must induce additional perturbations in embryonic
morphogenesis. Some phenotypic overlap between KCS
and the autosomal-recessive disorder Sanjad-Sakati syn-
drome might indicate a functional relationship between
FAM111A and TBCE. The pathogenic mechanism associ-
ated with TBCE mutations remains undetermined; it is
tempting to speculate that the two proteins might be inter-
linked in a common regulatory pathway.
In summary, the genetic data indicate that recurrent het-
erozygous mutations in FAM111A are the cause of KCS and
OCS and point to a hitherto unknown role of FAM111A in
the activation of the PTH axis. The nature and localization
of these mutations suggest that they disrupt the binding of
FAM111A to partner protein(s). These proteins and their
regulatory network remain to be discovered.Supplemental Data
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